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Objective: We examined the effects of an aerobic exercise intervention on adiposity outcomes that may be involved in the
association between physical activity and breast cancer risk.
Design: This study was a two-centre, two-armed, randomized controlled trial. The 1-year-long exercise intervention included
45min of moderate-to-vigorous aerobic exercise five times per week, with at least three of the sessions being facility based.
The control group was asked not to change their activity and both groups were asked not to change their diet.
Subjects: A total of 320 postmenopausal, sedentary, normal weight-to-obese women aged 50–74 years who were cancer-free,
nondiabetic and nonhormone replacement therapy users were included in this study.
Measurements: Anthropometric measurements of height, weight and waist and hip circumferences; dual energy X-ray
absorptiometry measurements of total body fat; and computerized tomography measurements of abdominal adiposity were
carried out.
Results: Women in the exercise group exercised a mean of 3.6 days (s.d.¼1.3) per week and 178.5min (s.d.¼76.1) per week.
Changes in all measures of adiposity favored exercisers relative to controls (Po0.001). The mean difference between groups
was: 1.8 kg for body weight; 2.0 kg for total body fat; 14.9 cm2 for intra-abdominal fat area; and 24.1 cm2 for
subcutaneous abdominal fat area. A linear trend of greater body fat loss with increasing volume of exercise was also observed.
Conclusion: A 1-year aerobic exercise program consistent with current public health guidelines resulted in reduced adiposity
levels in previously sedentary postmenopausal women at higher risk of breast cancer.
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Introduction
Increased adiposity negatively impacts health including
overall mortality; a wide range of chronic diseases including
diabetes, coronary heart disease and cancer; and a poor
quality of life.1–4 Overweight and obesity are prevalent
worldwide,5–7 exceeding 60% in the United States,7 and
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globally their rates are increasing.8–12 Thus, developing and
testing interventions to treat this condition is a priority,
particularly in the context of effecting downstream chronic
diseases. The high prevalence of overweight and obesity
among postmenopausal women, nearing 50% in countries
such as Canada,13 increases their risk for the many adverse
consequences of increased adiposity.14
Intervening with physical activity may be particularly
appropriate in this population. Physical activity seems to be
efficacious for weight stability without intervening on diet,
but because of the paucity of large trials in postmenopausal
women, it is unclear whether it can lead to a significant
reduction in adiposity in this population.1,15–19 Numerous
observational studies suggest that physical activity reduces
the risk of postmenopausal breast cancer,20–22 and that
activity carried out after menopause continues to lead to a
reduction in risk.1,23–25 This effect may operate through a
reduction in adiposity (postmenopausal breast cancer risk
could be lowered by as much as 20%26,27or more28 with at
least 10 kg weight loss), but there also seem to be effects over
and above a reduction in adiposity.1 Other than alcohol
intake, few modifiable breast cancer risk factors are known.29
The Alberta Physical Activity and Breast Cancer Prevention
(ALPHA) Trial was designed to increase the understanding of
the biological mechanisms that mediate the inverse associa-
tion between physical activity and breast cancer risk.
Specifically, it used a randomized, controlled design with a
large sample size to examine whether an intensive aerobic
exercise intervention influenced the primary end points of
adiposity and endogenous sex hormone concentrations, as
well as the secondary end points of mammographic density,
insulin-like growth factors, insulin resistance and circulating
markers of obesity and inflammation. We previously
reported the results from this trial on the sex hormones
outcomes.30 This paper reports the effects of the exercise
intervention on both total and abdominal adiposity, as
assessed with dual X-ray absorptiometry and computed
tomography. It addresses a gap in the scientific literature
for randomized controlled trials carried out in postmeno-
pausal women of exercise interventions that have higher
volume and longer duration and that quantify adiposity
with direct imaging methods.31 The ALPHA trial also
assessed the effect of physical activity independent of
a dietary intervention on potential breast cancer risk
mediators in order to extend scientific understanding of
the mechanisms underlying risk reduction.
Methods
Setting and participants
The design and methods for the ALPHA trial have been
previously presented.30 In brief, this study was a two-centre,
randomized trial carried out in postmenopausal women
living in the cities of Calgary and Edmonton in Alberta,
Canada. The study and protocol were approved by the
institutional review boards at the Alberta Cancer Board,
the Universities of Calgary and Alberta, and all participants
provided written informed consent. Women from the
general population were recruited through targeted mailings
to participants in the Alberta Breast Screening Program,
posters and brochures distributed to family physicians and
media campaigns. Specific eligibility criteria included age
50–74 years, postmenopausal, no previous cancer diagnosis,
no major comorbidities, acceptable baseline fitness test,
sedentary (o90min of weekly exercise or, if between 90 and
120min, having a VO2max level o34ml kg1min1), able to
do unrestricted physical activity,32 normal blood lipid and
hormone levels, BMI between 22 and 40kgm2, nonsmoker,
o14 drinks per week of alcohol, no medications or
exogenous hormones that might influence estrogen meta-
bolism and not currently or planning to undertake a weight
loss program. A short telephone screen identified eligible
women who then attended an information session in which
we explained the study, addressed questions and obtained
informed consent. Further screening included three
questionnaires, a mammogram, physician approval, blood
screening and a submaximal fitness test. Once eligibility was
assured, participants were randomized. Recruitment into the
study began in May 2003 and was completed in June 2006;
follow-up was completed by July 2007.
Randomization and blinding
The randomization sequence was created by the study biosta-
tistician (RB) using a random number program in S-plus (version
6 for UNIX/Linux, Insightful Corp., Seattle, WA, USA). Stratifica-
tion was carried out by center (Calgary, Edmonton) and BMI
(o27.5, X27.5mkg2), with blocks randomly sized between
four and six within strata to ensure an equal balance of study
participants randomized to each intervention condition. Num-
bered sealed opaque envelopes were created that were opened
only by the Study Coordinator in Calgary at the time of
randomization. All assessors of the primary outcome measures
were blinded to group assignment.
Intervention
The exercise prescription was moderate-to-vigorous intensity
aerobic exercise for at least 45min on 5 days per week for
1 year. At least three sessions per week were facility based
with on-site exercise trainers and the remaining sessions
were home based. Participants wore heart rate monitors
(Polar A3, Polar Electro Oy, Kempele, Finland) to ensure that
at least half of their total workout time was at 70–80% of
their heart rate reserve. They were instructed to warm up for
5min, cool down for 5–10min and stretch. The prescription
ramped up over the first 3 months starting with three weekly
sessions of 15–20min at 50–60% of the heart rate reserve.
Within these general parameters, the program was indivi-
dualized to the age and fitness level of each participant. Several
methods were used to increase success in meeting the exercise
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prescription, including scheduling of all facility-based sessions
and telephone follow-up of missed sessions, plans for vacations
and return after illness or injury, group sessions to permit
interaction between participants, a comprehensive educational
package highlighting issues of relevance to women starting an
exercise program, incentives that were awarded when program
milestones were reached, regular newsletters and a study
website. Adherence was monitored by weekly exercise logs
completed by the participants and the trainers. Women in the
control group were asked to maintain their regular lifestyle.
Both exercise and control participants were instructed not to
change their usual diet.
Measures at baseline and 1 year
Data on demographic characteristics and medical and
reproductive history were obtained from a self-administered
questionnaire at baseline; all other measures were taken at
baseline and at 1 year. Past year dietary intake was assessed
using the National Cancer Institute’s 124-item Diet History
Questionnaire previously adapted for use in Canada,33 and
occupational, household and recreational physical activity
were assessed using the validated Past Year Total Physical
Activity Questionnaire.34 A modified Balke treadmill
protocol was used to assess physical fitness by estimating
maximum oxygen consumption (VO2max) from submaximal
exercise intensities. Oxygen consumption at the age-
predicted maximum heart rate (that is, 220-age) was
estimated by extrapolating from the stage of the test in
which the heart rate reached 85% of the age-predicted
maximum heart rate using the American College of
Sports Medicine metabolic equations for estimating oxygen
consumption at the workload of each stage.35
Anthropometric measurements were made in duplicate;
if the two measurements were discrepant (that is, not
identical), a third measurement was taken and the average
of the two closest was used in the analyses. Weight and
height measurements were made using a balance beam scale
and a stadiometer. Waist and hip circumferences were
measured to the nearest 0.1 cm using a metal tape measure.
Body mass index was calculated as weight/height2 (kgm2).
Total body fat and body fat percentage were assessed using
whole body dual X-ray absorptiometry scans. In Calgary at
the Foothills Medical Centre, scans were carried out on a
Hologic QDR 4500W scanner in whole body mode and
analyzed with software version 11.2.1 (Hologic Inc, Bedford,
MA, USA). In Edmonton at the University of Alberta, scans
were carried out on a Lunar Prodigy scanner in either
standard mode or thick mode and analyzed with enCORE
Software 6.70.01 before November 2004 and 8.60 after
November 2004 (Lunar General Electric Medical Systems,
Madison, WI, USA). Percent body fat was calculated as
100% (fat mass/(fat massþ lean mass)). Fifteen scans that
were analyzed with both software versions showed that for
percent body fat, the correlation was very high (r¼0.9997),
with a mean absolute difference of 0.01. A variable composi-
tion phantom (Bio-Imaging VCP, Newton, PA, USA) was
scanned at both sites at the initiation and completion of the
study and determined that no standardization was necessary
for comparability; the scans of the phantom differed by less
than 0.6%.
Intra-abdominal and subcutaneous fat were measured with a
single computed tomography slice at the umbilicus. Scans were
carried out at the Alberta Cancer Board facilities; in Calgary
using a PQ5000 VisionMaster CT scanner (Marconi, Cleveland,
OH, USA) and in Edmonton using a MX8000 multi-slice CT
Scanner (Phillips Medical Systems, Cleveland, OH, USA). The
study radiologist (TT) used image analysis software from Philips
Medical Systems on a workstation (Silicone Graphics Inc.,
Sunnyvale, CA, USA) to identify and demarcate the thresholds
between the subcutaneous and intra-abdominal area. The
reliability of the reading of the computed tomography scans
was very high (intraclass correlation 40.99).
Sample size
The sample size needed to detect differences in the primary
end points of body composition and endogenous estrogen
concentrations were calculated based on comparing the
means of two independent samples.36 As a smaller effect size
was anticipated for estrogen outcomes, the sample size was
set at 150 participants per group to detect changes of 10–20%
in these outcomes, with 80% power at an a¼0.05. This
sample size provided a power of499% to detect anticipated
changes of 5–10% in the adiposity outcomes.15,37 To allow
for study dropouts, 160 participants were enrolled per group.
Statistical analyses
The main analyses included participants with complete data
at baseline and at 1 year, keeping individuals in the group to
which they were randomized regardless of their adherence.
The difference in the mean change in the outcomes from
baseline to 1 year between the exercise and control groups
was tested with two-sample t-tests. For comparison, the
analyses were repeated to include the few participants with
missing outcome data by assuming that no change occurred
in the outcomes. We also examined the statistical signifi-
cance of the interaction terms between intervention group
and the stratification variables for randomization, study
center and baseline BMI (p27.5,427.5 kgm2). In a post hoc
analysis, the mean changes from baseline to 1 year was
compared between controls and three groups of exercisers on
the basis of categories predefined by public health guidelines
and the prescription in this study (o150min per week,
150–225min per week and 4225min per week).1,38,39 All
statistical tests were two-sided with a level of significance set
at 0.05. Analyses were carried out using SAS (Version 9.1, SAS
Institute Inc., Cary, NC, USA).
Results
Of 3454 women assessed for eligibility, 1965 did not meet
the inclusion criteria, 274 were excluded for other reasons,
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895 refused participation and 320 women were randomized,
with 165 women from Edmonton and 155 from Calgary
(Figure 1). Baseline characteristics of the two groups were
similar (Table 1). Nine women were lost to follow-up, one
died for reasons unrelated to the trial and eight were no
longer interested or too busy. Over the course of the trial no
adverse events or side effects were reported in women
randomized to the exercise intervention.
Women in the exercise group completed an average of
3.6 sessions per week (s.d.¼1.3) for a mean duration of
178.5min (s.d.¼76.1).30 Objectively measured average heart
rate was 62.2% (s.d.¼9.8) of the estimated heart rate reserve.
As assessed using the Past Year Total Physical Activity
Questionnaire, 23% (37/160) of controls reported at least
150min per week of total activity over the intervention year;
however, recreational activity increased far less in controls
than in exercisers (3.2 vs 20.2 MET-hours per week;
Po0.001).40,41 Furthermore, aerobic fitness increased
significantly more in exercisers than in controls (3.9 vs
0.7ml kg1min1; Po0.001, corresponding to a per cent
change of 14.2 vs 2.6%). Mean energy intake decreased
among controls relative to exercisers (161 vs 45 kcal per day;
P¼0.01).
The mean decrease in adiposity between baseline and
1 year was significantly greater in exercisers relative to the
controls (Po0.001) (Table 2). Exercisers lost 2.3 kg body
weight, corresponding to a 3.0% decrease, whereas controls
Figure 1 Recruitment, randomization and follow-up of participants in the Alberta Physical Activity and Breast Cancer Prevention Trial.
Table 1 Characteristics of participants at baseline in the Alberta Physical
Activity and Breast Cancer Prevention Trial, n¼320
Characteristic Exercisers
(n¼160)
Controls
(n¼160)
Age (years) 61.2 (5.4) 60.6 (5.7)
No (%) of participants
Employed full time 82 (55) 79 (51)
Educated beyond high school 112 (70) 102 (64)
Married or in common-law relationship 113 (71) 125 (78)
White/Caucasian 144 (91) 145 (91)
Total energy intake (kcal per d) 1551 (599) 1527 (535)
Past year total physical activity
(MET-hours per week)
114.2 (57.6) 129.1 (77.9)
Maximal oxygen consumption
(ml kg1min1)
27.1 (6.2) 26.8 (6.0)
Adiposity
Weight (kg) 75.6 (13.0) 76.3 (12.7)
Body mass index (kgm2) 29.1 (4.5) 29.2 (4.3)
Waist circumference (cm) 88.8 (10.6) 88.8 (10.5)
Hip circumference (cm) 109.3 (9.8) 110.6 (10.1)
DXA: total body fat (kg) 30.9 (8.2) 31.3 (8.6)
DXA: percent body fat 42.2 (4.9) 42.4 (5.7)
CT: abdominal cross sectional area (cm2) 723.8 (164.1) 732.8 (170.0)
CT: abdominal fat area (cm2) 425.8 (154.5) 439.2 (162.2)
CT: intra-abdominal fat area (cm2) 101.4 (55.4) 103.2 (56.0)
CT: abdominal subcutaneous
fat area (cm2)
324.4 (116.0) 336.0 (123.5)
Abbreviations: CT, computed tomography; DXA, dual X-ray absorptiometry.
Note: Values are means (s.d.) unless stated otherwise.
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lost 0.5 kg, equal to a 0.6% decrease. The body weight lost
largely constituted of body fat; exercisers lost 2.4 kg body
fat, corresponding to a 7.7% decrease, whereas controls
lost 0.4 kg, equal to a 1.3% decrease. Abdominal fat area
decreased in exercisers, with a mean of 48.5 cm2, of which
16.5 cm2 was intra-abdominal fat area; controls also experi-
enced a small mean decrease in abdominal fat area (9.6 cm2)
of which 1.6 cm2 was intra-abdominal fat area. The only
nonstatistically significant difference was in lean body mass,
which did not decrease among exercisers, but did decrease by
0.1 kg in the control group. If the few participants with
missing outcome data were included by assuming no
change, or if the baseline value of the outcome measure
and covariates were included, the results were similar (data
not shown).
The association between the intervention and change in
adiposity was similar in each BMI stratum (P-value for
interaction terms40.05; data not shown). The results
stratified by study center suggested that greater differences
between exercisers and controls were achieved in Edmonton
than in Calgary (data not shown). Although women in
Edmonton were heavier than women in Calgary, as noted
above, baseline adiposity did not modify the effect of the
intervention. In addition, the exercise group in Edmonton
completed more facility-based sessions per week than
exercisers in Calgary (2.7 vs 2.1; Po0.001) and exercised at
higher intensity levels (rate of perceived exertion 13.5 vs
11.8; Po0.001).
Greater decreases in adiposity were achieved with a greater
mean duration spent at each week exercising (Figure 2).
Table 2 Changes in adiposity between baseline and 12 months
Adiposity measure Exercisers Controls Difference P-valuea
Weight (kg) 2.3 (2.9 to 1.7) 0.5 (1.0 to 0.1) 1.8 (2.6 to 1.0) o0.001
Body mass index (kgm2) 0.9 (1.1 to 0.6) 0.2 (0.4 to 0.1) 0.7 (1.0 to 0.4) o0.001
Waist circumference (cm) 2.2 (3.0 to 1.5) 0.1 (0.7 to 0.9) 2.3 (3.4 to 1.2) o0.001
Hip circumference (cm) 2.4 (3.2 to 1.7) 0.8 (1.4 to 0.1) 1.7 (2.6 to 0.7) o0.001
DXA: total body fat (kg) 2.4 (2.8 to 1.9) 0.4 (0.8 to 0.0) 2.0 (2.6 to 1.3) o0.001
DXA: total body fat (%) 2.0 (2.4 to 1.5) 0.2 (0.5 to 0.1) 1.8 (2.3 to 1.2) o0.001
CT: abdominal cross sectional area (cm2) 39.2 (48.0 to 30.4) 3.7 (12.7 to 5.3) 35.5 (48.0 to 23.0) o0.001
CT: abdominal fat area (cm2) 48.5 (57.4 to 39.6) 9.6 (19.0 to 0.1) 38.9 (51.9 to 26.0) o0.001
CT: intra-abdominal fat area (cm2) 16.5 (19.6 to 13.5) 1.6 (5.4 to 2.1) 14.9 (19.8 to 10.1) o0.001
CT: subcutaneous abdominal fat area (cm2) 32.0 (38.9 to 25.1) 7.9 (14.6 to 1.3) 24.1 (33.5 to 14.5) o0.001
CT: lean body mass (kg) 0.0 (0.3 to 0.2) 0.1 (0.3 to 0.1) 0.1 (0.2 to 0.4) 0.564
Abbreviations: CT, computed tomography; DXA, dual X-ray absorptiometry. aTesting the mean difference between exercisers and controls in the change between
baseline and 12 months. Values are mean (95% confidence interval).
Pe
rc
en
ta
ge
 c
ha
ng
e
–0.6 –0.2
–3.3
–4.9*
*
–1.3
–2.5
–8.1
–11.4
*
*
–1.6
–10.4
–15.0
–24.5
*
*
*
0
–5
–10
–15
–20
–25
Controls <150 150-225 >225 Controls <150 150-225 >225 Controls <150 150-225 >225
Weight Total body fat Intra-abdominal fat area
Exercisers
mean minutes per week
Exercisers
mean minutes per week
Exercisers
mean minutes per week
Figure 2 Percentage change in measures of adiposity between baseline and 12 months, in controls and exercisers stratified by average minutes per week spent
exercising. *Significant difference compared with control group (Po0.05).
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Compared with controls, whose percentage decrease in body
fat was 1.3%, the percentage decrease in exercisers with a
mean weekly duration o150, 150–225 and X225min was
2.5%, 8.1 and 11.4%, respectively. An even greater decrease
in intra-abdominal fat was seen across these four groups (1.6
vs 10.4 vs 15.0 vs 24.5%).
Using categories suggested for clinical relevance (Table 3),42
in this study, weight loss45% was achieved in 28% (43/152)
of the exercisers compared with 14% (21/155) of the
controls. Conversely, weight gain (43%) was seen in 8%
(12/152) of the exercisers compared with 12% (19/155) of the
controls. The likelihood of clinically relevant weight loss
increased with greater duration of exercise.
Discussion
This yearlong aerobic exercise intervention among postme-
nopausal women resulted in statistically significant reduc-
tions in overall and abdominal adiposity without any
intervention to change dietary intake. Furthermore, women
in the exercise group, who achieved a higher duration of
physical activity, experienced greater average decreases in
adiposity. The combination of facility- and home-based
program was achievable and resulted in statistically signifi-
cant increases in physical activity.
Our study differed from previous randomized
trials1,15,16,18,19,43–56 of exercise interventions among post-
menopausal women that were at least 6 months duration
and examined adiposity outcomes. It had a large sample size,
used quantitative imaging techniques that are preferable for
measuring adiposity, had a low drop-out rate, excellent
adherence and used a supervised, high volume of exercise. Of
these trials, only two studies carried out by Irwin et al. in the
United States15,56 and Velthuis et al. in the Netherlands47
were sufficiently comparable with ours with respect to study
design, exercise volume and outcome measures. Irwin et al.15
found statistically significant decreases in adiposity of a
smaller magnitude than that in our trial and a dose–response
with increasing exercise adherence, whereas the trial by
Velthuis and colleagues56 only found statistically significant
decreases for total body fat. The Dose–Response to Exercise
in postmenopausal Women trial carried out by Church
et al.44,46 was designed to test the effects of three different
doses of exercise on cardiorespiratory fitness over a period of
6 months in sedentary postmenopausal, overweight and
obese women with elevated blood pressure. These investiga-
tors found statistically significant decreases in waist circum-
ference among exercisers, but not in weight or percent
body fat, and no dose–response trend was observed.44,46 A
statistically significant effect might have been observed
given a longer duration; alternatively, the absence of a
dose–response trend may be explained by compensatory
increases in energy intake that increase as the weekly volume
of exercise increases.46 In our study, energy intake decreased
among controls relative to exercisers, suggesting that at least
some compensation by energy intake was made.
In this study and most other exercise studies, weight
change is largely accounted for by a loss of fat mass with the
preservation of lean mass.15,16,43,49 Although the consensus
is that overweight or obese subjects will experience greater
changes in adiposity than those of normal weight,1,15,16,57,58
in our study, we did not find that baseline BMI modified the
effect of the intervention on changes in adiposity, possibly
because most women were overweight or obese.
A recent comprehensive review concluded that without
caloric restriction, aerobic exercise in the range of 13–26
MET-hours per week results in decreases in abdominal
adiposity.1 This conclusion is supported by our study in
which 17 MET-hours per week on average over the interven-
tion year were expended by the exercisers relative to
controls. With this volume of exercise, average reductions
in intra-abdominal fat and subcutaneous abdominal fat of 17
and 10%, respectively, were achieved. Other studies includ-
ing postmenopausal women have also observed reductions
in abdominal adiposity with aerobic exercise.15–18,44,59 In
addition, we found larger reductions with longer weekly
duration of exercise; women who exercised 4225min per
week had nearly 25% reductions in intra-abdominal fat
observed. This dose–response relationship is supported by
previous randomized and nonrandomized trials (reviewed in
Ohkawara et al.60), but was not observed in the Dose–
Response to Exercise in postmenopausal Women trial.44 Our
study and others also suggest that intra-abdominal fat may
be lost in a higher proportion than overall fat in response to
increased energy expenditure, and that intra-abdominal fat
may be decreased even in the absence of significant weight
loss or after controlling for change in weight.15,16,46,58,61
Even after controlling for percent change in total fat mass,
Table 3 Participants experiencing clinically meaningful changes in weight, by group and by categories of exercise duration in exercisers
Weight change category Controls Exercisers Exercisers, by minutes per week
o150 150–225 4225
Meaningful loss (X5%)a 21 (14) 43 (28) 4 (11) 19 (28) 20 (43)
Minor fluctuation (43% to o5%) 10 (6) 25 (16) 3 (8) 12 (18) 10 (21)
Maintenance (±3%) 105 (68) 72 (47) 25 (66) 32 (48) 15 (32)
Gain (43%) 19 (12) 12 (8) 6 (17) 4 (6) 2 (4)
Values are numbers (column percentages). aChange in weight as a percentage of baseline body weight.
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exercisers in the current study still achieved a statistically
significant change in intra-abdominal fat relative to controls
(data not shown).
Lower adiposity, intertwined with other related mechan-
isms such as levels of endogenous sex hormones, metabolic
hormones, growth factors and immune factors, likely has a
role in the association between physical activity and breast
cancer.62–64 Abdominal adiposity is etiologically relevant to
breast cancer risk;65 positive associations with waist–hip
ratio, waist circumference or other measures of central
adiposity have been found in most studies of postmenopau-
sal breast cancer risk.3,66–69 It remains to be seen whether
adding a dietary intervention component has additive effects
on reductions in adiposity, particularly on intra-abdominal
adiposity.70
The limitations of this study include the lack of compli-
ance amongst controls, as 23% reported4150min per week
of physical activity during the intervention, and the limited
generalizability of the sample because of the exclusion
criteria, including the presence of comorbid conditions such
as diabetes and hypercholesterolemia. A per protocol
analysis in which participants in either the exercise or
control group achieving o150min per week were compared
with participants in either group achieving X150min per
week indicated that the difference in the weight loss between
these groups was almost exactly similar to that between the
intervention groups (data not shown). Furthermore, despite
instructions not to change dietary energy, 20% of exercisers
and 31% of controls decreased their caloric intake4300 kcal
per day and 14% of exercisers and 8% of controls increased
their caloric intake 4300 kcal per day. Although food
frequency questionnaires are limited as means of measuring
dietary intake, because responses are self-reported and
subject to measurement error, we repeated the same
measurement at the beginning and end of the trial in both
exercisers and controls.
It is of importance to note that this study was designed as
an efficacy trial, not an effectiveness study, and future
research will evaluate how likely uptake of this level of
exercise in postmenopausal women would be and how to
develop strategies to enhance adoption and maintenance.
Furthermore, the level of exercise that was prescribed for our
study population is comparable with that found amongst the
highest activity groups in observational studies20,21 and is
also within the range of public health recommendations of
exercise for chronic disease reduction.1 Although this study
has provided some preliminary evidence on how aerobic
exercise can be used to decrease adiposity levels that may be
associated with cancer risk, it has not addressed the question
of the exact dose and type of activity needed for the optimal
reduction in adiposity levels. Our preliminary findings from
analyses conducted within the exercise arm of the trial need
to be substantiated in a future randomized controlled trial
that compares different doses of activity in separate arms of
the trial and the consequent effect on adiposity and other
metabolic hormones. Finally, we recognize that in clinical
practice, a multipronged approach should be used to
decrease chronic disease risk including intervening on other
modifiable lifestyle risk factors. Results from one observa-
tional study suggest that postmenopausal breast cancer risk
may be reduced by 10% for every 5 kg of weight lost from a
woman’s highest body weight attained earlier in life,27 which
translates into a risk reduction of 4–5% in our exercise group.
Higher risk reductions for breast cancer (and other chronic
disease associated with obesity) might be attained using a
weight loss strategy that incorporates both physical activity
and dietary changes.
In conclusion, this trial has addressed a gap identified in
the scientific literature for rigorous and well-designed
randomized controlled trials of higher volume, longer
duration and exercise interventions that quantify using
direct imaging methods the impact of exercise on body
composition.31 It provides direct empirical evidence that
previously sedentary, mostly overweight, postmenopausal
women can achieve and sustain high levels of aerobic
exercise that result in statistically significant reductions in
all measures of adiposity. These levels of change in adiposity
through exercise could be beneficial for chronic disease risk
reduction.
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